Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus

Larissa Avilés-Santa, Karin Salinas, Beverley A Huet, Philip Raskin

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Objective: The purpose of this study is to compare score systems used to estimate the risk for cardiovascular disease (CVD) in young patients with poorly controlled type 2 diabetes. Methods: Fifty-seven Latin American patients with type 2 diabetes, between the ages 18 and 45 years, were screened to participate in a clinical research study evaluating the effects of intensive insulin therapy on both traditional and nontraditional CVD risk factors. All women were premenopausal and had regular menstrual periods. Baseline reviews of cardiovascular (CV) risk scores, personal history, physical examination, and laboratory screening were performed. The Framingham Study Score system and the presence of features of the metabolic syndrome (MSyn) were recorded and compared. Results: Both genders had a comparable number of features of the MSyn, whereas according to the Framingham Score System, men had a slightly higher risk of CVD. Conclusions: The Framingham Score system is not an accurate device to estimate risk of CVD in premenopausal women with type 2 diabetes mellitus, who otherwise have a multiple features of the MSyn. If used to estimate risk of CVD, the Framingham score system could underestimate the risk of CVD in both young men and women with type 2 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)69-74
Number of pages6
JournalJournal of Diabetes and Its Complications
Issue number2
StatePublished - 2006


  • Cardiovascular risks
  • Central obesity
  • Latinos
  • Premenopausal women
  • Type 2 diabetes mellitus
  • Waist circumference

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this